Disruption of the bone morphogenetic protein receptor 2 pathway in nitrofen-induced congenital diaphragmatic hernia

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 98, Issue 4, 2013, Pages 304-309

  Gosemann, Jan Hendrik ^a,b   Friedmacher, Florian ^a   Fujiwara, Naho ^a   Alvarez, Luis A J ^a   Corcionivoschi, Nicolae ^a   Puri, Prem ^a,c  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

BMPR2; Congenital diaphragmatic hernia; Nitrofen; Pulmonary hypertension

Indexed keywords

BETA ACTIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITROFEN; SMAD PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL MICROSCOPY; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FETUS; GENE EXPRESSION; GESTATIONAL AGE; IMMUNOFLUORESCENCE MICROSCOPY; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

RATTUS;

BMPR2; CONGENITAL DIAPHRAGMATIC HERNIA; NITROFEN; PULMONARY HYPERTENSION;

ACTINS; ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HERNIA, DIAPHRAGMATIC; HUMANS; LUNG; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENYL ETHERS; PHOSPHOTYROSINE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84885862847     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.21065     Document Type: Article

References (25)

1. Alejandre-Alcazar MA, Shalamanov PD, Amarie OV, Sevilla-Perez J, Seeger W, Eickelberg O, Morty RE. 2007. Temporal and spatial regulation of bone morphogenetic protein signaling in late lung development. Dev Dyn 236(10):2825-2835.
2. Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW. 2002. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105(14):1672-1678.
3. Beurskens N, Klaassens M, Rottier R, de Klein A, Tibboel D. 2007. Linking animal models to human congenital diaphragmatic hernia. Birth Defects Res A Clin Mol Teratol 79(8):565-572.
4. Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC. 2009. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 104(10):1184-1191.
5. Chang YT, Ringman Uggla A, Osterholm C, Tran PK, Eklof AC, Lengquist M, Hedin U, Tran-Lundmark K, Frenckner B. 2012. Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol 302(11):L1159-L1166.
6. Corbett HJ, Connell MG, Fernig DG, Losty PD, Jesudason EC. 2012. ANG-1 TIE-2 and BMPR signalling defects are not seen in the nitrofen model of pulmonary hypertension and congenital diaphragmatic hernia. PLoS One 7(4):e35364.
7. Dewachter L, Adnot S, Guignabert C, Tu L, Marcos E, Fadel E, Humbert M, Dartevelle P, Simonneau G, Naeije R, Eddahibi S. 2009. Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J 34(5):1100-1110.
8. Frank DB, Lowery J, Anderson L, Brink M, Reese J, de Caestecker M. 2008. Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol 294(1):L98-L109.
9. Fujiwara N, Doi T, Gosemann JH, Kutasy B, Friedmacher F, Puri P. 2012. Smad1 and WIF1 genes are downregulated during saccular stage of lung development in the nitrofen rat model. Pediatr Surg Int 28(2):189-193.
10. Gosemann JH, Doi T, Kutasy B, Friedmacher F, Dingemann J, Puri P. 2012. Alterations of peroxisome proliferator-activated receptor gamma and monocyte chemoattractant protein 1 gene expression in the nitrofen-induced hypoplastic lung. J Pediatr Surg 47(5):847-851.
11. Gurbanov E, Shiliang X. 2006. The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension. Eur J Cardiothorac Surg 30(3):499-507.
12. Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM, West J. 2007. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol 292(6):L1473-L1479.
13. Hansmann G, de Jesus Perez VA, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, Rabinovitch M. 2008. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118(5):1846-1857.
14. Jankov RP, Kantores C, Belcastro R, Yi M, Tanswell AK. 2006. Endothelin-1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal rat. Pediatr Res 60(3):245-251.
15. Keijzer R, Puri P. 2010. Congenital diaphragmatic hernia. Semin Pediatr Surg 19(3):180-185.
16. Luong C, Rey-Perra J, Vadivel A, Gilmour G, Sauve Y, Koonen D, Walker D, Todd KG, Gressens P, Kassiri Z, Nadeem K, Morgan B, Eaton F, Dyck JR, Archer SL, Thebaud B. 2011. Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia. Circulation 123(19):2120-2131.
17. Moral-Sanz J, Menendez C, Moreno L, Moreno E, Cogolludo A, Perez-Vizcaino F. 2011. Pulmonary arterial dysfunction in insulin resistant obese Zucker rats. Respir Res 12:51.
18. Reynolds AM, Xia W, Holmes MD, Hodge SJ, Danilov S, Curiel DT, Morrell NW, Reynolds PN. 2007. Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 292(5):L1182-L1192.
19. Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, Morrell NW. 2002. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11(13):1517-1525.
20. Runo JR, Loyd JE. 2003. Primary pulmonary hypertension. Lancet 361(9368):1533-1544.
21. Southwood M, Jeffery TK, Yang X, Upton PD, Hall SM, Atkinson C, Haworth SG, Stewart S, Reynolds PN, Long L, Trembath RC, Morrell NW. 2008. Regulation of bone morphogenetic protein signalling in human pulmonary vascular development. J Pathol 214(1):85-95.
22. Taira Y, Yamataka T, Miyazaki E, Puri P. 1998. Adventitial changes in pulmonary vasculature in congenital diaphragmatic hernia complicated by pulmonary hypertension. J Pediatr Surg 33(2):382-387.
23. Yang X, Long L, Reynolds PN, Morrell NW. 2011. Expression of mutant BMPR-II in pulmonary endothelial cells promotes apoptosis and a release of factors that stimulate proliferation of pulmonary arterial smooth muscle cells. Pulm Circ 1(1):103-110.
24. Yang X, Long L, Southwood M, Rudarakanchana N, Upton PD, Jeffery TK, Atkinson C, Chen H, Trembath RC, Morrell NW. 2005. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 96(10):1053-1063.
25. Yuan JX, Rubin LJ. 2005. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation 111(5):534-538.